APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Healthcare Services

₹6922.50-52.00(-0.75%)

Market Closed as of May 20, 2025, 15:30 IST

What does Apollo Hospitals Enterprises Ltd. do?

Hospital•Healthcare•Mid Cap

Apollo Hospitals Enterprises is a leading healthcare company based in Chennai, India, with a stock ticker of APOLLOHOSP and a substantial market capitalization of Rs. 89,378.2 Crores.

The company provides a comprehensive range of healthcare services, both domestically and internationally. Its operations are segmented into several areas, including Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others. The facilities operated by Apollo Hospitals encompass primary, secondary, and tertiary care, along with specialized services in various medical fields such as:

Cardiac sciences
Orthopedics
Oncology
Neurosciences
Emergency care
Robotic surgery
Organ transplants

In addition to clinical services, Apollo Hospitals also offers project consultancy, health insurance, educational services through medical colleges and e-learning platforms, and research initiatives.

Apollo Hospitals manages a diverse network of health-focused facilities, which feature:

Pharmacies and primary care clinics
Specialized birthing and dialysis centers
Diabetes management facilities
Dental clinics and daycare centers
Home healthcare services
A digital health platform, Apollo 24/7, and an online pharmacy at www.apollopharmacy.in.

Incorporated in 1979, Apollo Hospitals Enterprises reported a trailing 12-month revenue of Rs. 21,313 Crores, demonstrating robust growth of 51.7% over the past three years. The company also distributes dividends to its investors, with a yield of 0.4% per year and a dividend payout of Rs. 25 per share over the last year.

Industry Group:Healthcare Services

Employees:83,147

Website:www.apollohospitals.com

Valuation
Market Cap	99.54 kCr
Price/Earnings (Trailing)	73.78
Price/Sales (Trailing)	4.67
EV/EBITDA	32.53
Price/Free Cashflow	125.87
MarketCap/EBT	53.49

Fundamentals
Revenue (TTM)	21.31 kCr
Rev. Growth (Yr)	14.6%
Rev. Growth (Qtr)	-0.65%
Earnings (TTM)	1.35 kCr
Earnings Growth (Yr)	49.14%
Earnings Growth (Qtr)	-4.12%

Profitability
Operating Margin	8.73%
EBT Margin	8.73%
Return on Equity	17.04%
Return on Assets	6.9%
Free Cashflow Yield	0.79%

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Category	APOLLOHOSP	Healthcare
PE	74.40	38.95
PS	4.71	7.02
Growth	15.1 %	-1.3 %

Share Holdings

Understand Apollo Hospitals Enterprises ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

As of 2025-03-31

Shareholder Name	Holding %
M/s. PCR Investments Ltd	18.93%
LIFE INSURANCE CORPORATION OF INDIA	3.77%
Ms. Suneeta Reddy	3.36%
HDFC TRUSTEE COMPANY LIMITED	2.38%
MIRAE ASSET ELSS TAX SAVER FUND	1.88%
GOVERNMENT OF SINGAPORE	1.76%
Ms. Sangita Reddy	1.69%
Ms. Shobana Kamineni	1.56%
SBI NIFTY 50 ETF	1.41%
AXIS MUTUAL FUND TRUSTEE LIMITED	1.23%
SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES	1.17%
GOVERNMENT PENSION FUND GLOBAL	1.13%
Mr. K Vishweshwar Reddy	1.1%
KOTAK FUNDS - INDIA MIDCAP FUND	1.07%
FRANKLIN INDIA FLEXI CAP FUND	1.06%
NIPPON LIFE INDIA TRUSTEE LTD	1.04%
Ms. Preetha Reddy	0.73%
Mr. Karthik Anand	0.24%
Mr. Harshad Reddy	0.23%
Ms. Sindoori Reddy	0.22%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Description	Share	Value
Healthcare services	50.5%	2.8 kCr
Digital Health & Pharmacy distribution	42.4%	2.4 kCr
Retail health & diagnostics	7.0%	389.6 Cr
Total		5.5 kCr

Latest News and Updates from Apollo Hospitals Enterprises

Updated May 4, 2025

Apollo Hospitals Enterprise (APOLLOHOSP) is currently experiencing a downturn with a year-to-date decline of 4.38% and trading 0.55% lower at Rs 6,954.05. Despite some positive long-term performance metrics, such as a 406.03% increase over five years, the stock has been facing pressure due to decreased mutual fund and foreign institutional investor holdings. The company's high TTM P/E ratio of 80.08 compared to the sector average of 23.01 raises concerns about its valuation. Analyst recommendations are mixed, indicating uncertainty among investors.

The Bad News

Source-Mint

The stock is trading 0.55% lower and has seen a year-to-date decline of 4.38%.

Source-Mint

Mutual fund and foreign institutional investor holdings have decreased to 12.77% and 45.27%, respectively.

Source-Mint

The company's TTM P/E ratio of 80.08 is significantly higher than the sector average of 23.01, raising concerns about its valuation.

The Good News

Source-The Financial Express

Apollo Hospitals Enterprise has shown a robust five-year performance with an increase of 406.03%.

Source-The Financial Express

The stock has demonstrated a monthly return of 5.17%, indicating some recovery in recent weeks.

Source-Mint

Among 24 analysts, 21 recommend a buy or strong buy for the stock, reflecting a level of confidence in its long-term prospects.

This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.

Investor Care
Dividend Yield	0.36%
Dividend/Share (TTM)	25
Shares Dilution (1Y)	0.00%
Diluted EPS (TTM)	91.11

Financial Health
Current Ratio	1.47
Debt/Equity	0.61
Debt/Cashflow	0.61

Balance Sheet for Apollo Hospitals Enterprises

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	17.8%	325	276	254	217	301	360
Current investments	1.9%	697	684	562	292	324	501
Loans, current	43.6%	113	79	80	80	6.08	4.08
Total current financial assets	-6.9%	3,054	3,280	3,186	2,820	2,945	3,199
Inventories	6.8%	127	119	112	98	124	147
Current tax assets	-	-	-	63	-	10	-
Total current assets	-8.2%	3,372	3,675	3,506	3,151	3,304	3,455
Property, plant and equipment	-0.3%	5,953	5,971	5,355	5,049	5,056	5,101
Capital work-in-progress	71.9%	295	172	97	89	43	22
Goodwill	-	0	0	0	0	0	0
Non-current investments	27.3%	2,467	1,938	1,938	1,925	1,886	1,558
Loans, non-current	47.1%	360	245	225	236	315	32
Total non-current financial assets	26.4%	2,985	2,361	2,400	2,292	2,296	1,653
Total non-current assets	8.6%	9,478	8,730	7,994	7,630	7,508	6,953
Total assets	3.6%	12,850	12,405	11,500	10,780	10,812	10,408
Borrowings, non-current	-5.9%	1,681	1,786	1,621	1,520	1,837	1,908
Total non-current financial liabilities	-3.5%	2,841	2,944	2,577	2,225	2,505	2,584
Total non-current liabilities	-3.3%	3,216	3,324	2,949	2,612	2,876	3,108
Borrowings, current	20.7%	205	170	175	240	132	116
Total current financial liabilities	4%	1,207	1,161	1,035	1,062	1,214	1,017
Provisions, current	22%	123	101	123	77	78	71
Total current liabilities	5.4%	1,444	1,370	1,257	1,243	1,400	1,189
Total liabilities	-0.7%	4,659	4,694	4,206	3,856	4,276	4,297
Equity share capital	0%	72	72	72	72	72	72
Total equity	6.2%	8,190	7,711	7,294	6,925	6,536	6,111
Total equity and liabilities	3.6%	12,850	12,405	11,500	10,780	10,812	10,408

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	184%	1,435	506	472	433	562	583
Current investments	2%	698	684	562	292	325	501
Loans, current	-48.7%	3	4.9	5.67	5.63	6.08	4.08
Total current financial assets	51.4%	6,514	4,304	4,117	3,602	3,621	3,497
Inventories	-2.6%	448	460	423	390	436	432
Current tax assets	-	-	-	252	-	214	-
Total current assets	39%	7,338	5,280	5,140	4,337	4,567	4,121
Property, plant and equipment	5.9%	9,043	8,540	7,771	7,432	7,209	7,235
Capital work-in-progress	23.3%	1,042	845	727	602	548	44
Investment property	-12.5%	3.1	3.4	3.75	4.06	4.37	4.68
Goodwill	0%	1,012	1,012	1,011	986	952	923
Non-current investments	203.9%	314	104	290	96	101	96
Loans, non-current	435.7%	31	6.6	6.9	8.37	6.08	8.03
Total non-current financial assets	73.5%	629	363	614	401	266	435
Total non-current assets	6.4%	12,210	11,473	10,421	10,091	9,408	9,093
Total assets	16.7%	19,548	16,753	15,561	14,428	13,975	13,214
Borrowings, non-current	70.8%	3,819	2,236	2,016	1,938	2,311	2,427
Total non-current financial liabilities	43.9%	6,081	4,227	4,409	4,052	4,260	4,359
Provisions, non-current	11.1%	81	73	56	57	55	23
Total non-current liabilities	39.1%	6,632	4,768	4,904	4,572	4,720	4,932
Borrowings, current	11.1%	1,029	926	994	773	249	208
Total current financial liabilities	6.7%	4,568	4,283	3,342	2,972	2,630	2,118
Provisions, current	16.2%	166	143	174	113	97	119
Current tax liabilities	-166.7%	0.8	1.3	4.05	2.8	5.86	3.02
Total current liabilities	7.2%	5,001	4,664	3,780	3,325	2,963	2,383
Total liabilities	23.3%	11,633	9,433	8,683	7,896	7,682	7,315
Equity share capital	0%	72	72	72	72	72	72
Non controlling interest	7.6%	414	385	369	334	300	254
Total equity	8.1%	7,915	7,320	6,878	6,531	6,292	5,899
Total equity and liabilities	16.7%	19,548	16,753	15,561	14,428	13,975	13,214

Is Apollo Hospitals Enterprises Better than it's peers?

Detailed comparison of Apollo Hospitals Enterprises against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
MAXHEALTH	Max Healthcare InstituteHospital	1.13 LCr	6.7 kCr	+8.32%	+38.36%	112.28	16.91	+24.67%	-4.60%
FORTIS	Fortis HealthcareHospital	51.27 kCr	7.62 kCr	+7.71%	+50.74%	62.19	6.73	+12.17%	+42.06%
NH	Narayana HrudayalayaHospital	35.41 kCr	5.48 kCr	-1.04%	+33.98%	45.15	6.47	+8.88%	+1.56%
MEDANTA	Global HealthHospital	31.99 kCr	3.65 kCr	-7.27%	-16.20%	63.06	8.76	+12.56%	+12.29%
KIMS	Krishna Institute of Medical SciencesHospital	25.6 kCr	2.9 kCr	-0.80%	+69.17%	67.39	8.82	+18.28%	+4.60%
LALPATHLAB	Dr. Lal PathlabsHealthcare Service Provider	23.4 kCr	2.49 kCr	+0.98%	+11.00%	55.39	9.4	+11.31%	+26.72%
METROPOLIS	Metropolis HealthcareHealthcare Service Provider	8.51 kCr	1.33 kCr	-1.07%	-9.69%	55.7	6.41	+13.76%	+21.84%

Income Statement for Apollo Hospitals Enterprises

Standalone figures (in Rs. Crores) / View Consolidated Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	11.5%	7,274	6,525	6,098	9,153	9,794	8,337
Other Income	18.5%	180	152	47	18	11	12
Total Income	11.7%	7,454	6,676	6,145	9,171	9,805	8,349
Cost of Materials	7.4%	1,999	1,861	1,929	1,330	1,532	1,392
Purchases of stock-in-trade	-	0	0	0	4,155	3,754	3,049
Employee Expense	15%	1,425	1,239	1,150	1,275	1,519	1,295
Finance costs	4.6%	250	239	244	344	426	268
Depreciation and Amortization	8.7%	399	367	363	436	482	300
Other expenses	17.7%	2,052	1,743	1,599	1,573	1,678	1,654
Total Expenses	12.4%	6,125	5,449	5,286	8,985	9,287	7,886
Profit Before exceptional items and Tax	8.2%	1,329	1,228	859	186	518	462
Exceptional items before tax	-	0	0	-6.74	-9.09	164	0
Total profit before tax	8.2%	1,329	1,228	852	177	682	462
Current tax	6.6%	322	302	40	62	205	111
Deferred tax	97.2%	-3.5	-159.77	239	9.48	6.94	49
Total tax	123.2%	318	143	280	72	212	160
Total profit (loss) for period	-6.9%	1,010	1,085	665	105	470	303
Other comp. income net of taxes	21.7%	-8.5	-11.14	-2.24	-5.58	0.75	-29.12
Total Comprehensive Income	-6.7%	1,002	1,074	663	100	471	274
Earnings Per Share, Basic	-6.9%	70.28	75.45	46.26	7.51	33.8	21.76
Earnings Per Share, Diluted	-6.9%	70.28	75.45	46.26	7.51	33.8	21.76
Debt equity ratio	-	-	025	-	082	082	088
Debt service coverage ratio	-	-	0.0231	-	0.0292	0.0292	0.0245
Interest service coverage ratio	-	-	0.0713	-	0.0427	0.0427	0.0424

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-3.7%	2,055	2,135	1,937	1,895	1,824	1,866
Other Income	-10.8%	108	121	27	46	52	65
Total Income	-4.1%	2,163	2,256	1,964	1,941	1,876	1,931
Cost of Materials	-2.1%	569	581	536	527	496	514
Employee Expense	-4.4%	394	412	381	384	350	358
Finance costs	-4.7%	62	65	64	69	61	60
Depreciation and Amortization	0%	108	108	103	115	97	93
Other expenses	-3.7%	580	602	549	534	527	515
Total Expenses	-3.2%	1,713	1,769	1,632	1,628	1,532	1,540
Profit Before exceptional items and Tax	-8%	449	488	332	312	344	391
Total profit before tax	-8%	449	488	332	312	344	391
Current tax	-12.6%	105	120	81	54	90	104
Deferred tax	150%	2.6	-2.2	-1.1	19	-8.8	-7.7
Total tax	-8.5%	108	118	80	74	81	96
Total profit (loss) for period	-7.6%	342	370	252	239	263	295
Other comp. income net of taxes	-2.9%	-2.5	-2.4	5	0.3	0.8	-8
Total Comprehensive Income	-7.7%	339	367	257	239	264	287
Earnings Per Share, Basic	-7.9%	23.76	25.71	17.51	16.61	18.28	20.5
Earnings Per Share, Diluted	-7.9%	23.76	25.71	17.51	16.61	18.28	20.5
Debt equity ratio	-	-	-	-	-	024	025
Debt service coverage ratio	-	-	-	-	-	0.0419	0.0281
Interest service coverage ratio	-	-	-	-	-	0.0696	0.0754

Consolidated figures (in Rs. Crores) / View Standalone Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	14.7%	19,059	16,612	14,663	10,560	11,247	9,617
Other Income	18%	106	90	78	45	27	31
Total Income	14.7%	19,166	16,703	14,741	10,605	11,274	9,649
Cost of Materials	7.4%	2,454	2,284	2,685	1,623	1,809	1,645
Purchases of stock-in-trade	16.9%	7,385	6,315	4,961	4,186	3,797	3,088
Employee Expense	16.3%	2,494	2,144	1,787	1,601	1,853	1,598
Finance costs	17.9%	449	381	379	449	533	327
Depreciation and Amortization	11.7%	687	615	601	573	620	396
Other expenses	13.6%	4,369	3,845	3,118	2,137	2,308	2,295
Total Expenses	14.4%	17,805	15,559	13,457	10,445	10,812	9,276
Profit Before exceptional items and Tax	19%	1,361	1,144	1,284	160	462	373
Exceptional items before tax	-	1.9	0	294	61	198	0
Total profit before tax	19.1%	1,362	1,144	1,578	221	660	373
Current tax	7.7%	437	406	238	76	214	126
Deferred tax	105.1%	8.7	-149.67	239	8.92	11	47
Total tax	74.5%	446	256	477	85	225	173
Total profit (loss) for period	10.7%	935	845	1,108	137	432	200
Other comp. income net of taxes	20.1%	-10.4	-13.27	-9.72	15	-0.6	-29.12
Total Comprehensive Income	11.3%	925	831	1,099	152	431	171
Earnings Per Share, Basic	9.9%	62.5	56.97	73.42	10.74	32.7	16.97
Earnings Per Share, Diluted	9.9%	62.5	56.97	73.42	10.74	32.7	16.97

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-1.1%	5,527	5,589	5,086	4,944	4,851	4,847
Other Income	70.3%	64	38	37	28	28	22
Total Income	-0.7%	5,591	5,628	5,123	4,972	4,878	4,869
Cost of Materials	-15.9%	626	744	690	638	603	632
Purchases of stock-in-trade	8.6%	2,292	2,110	1,911	1,914	1,944	1,840
Employee Expense	-2%	686	700	658	645	613	644
Finance costs	-6.8%	110	118	116	119	113	111
Depreciation and Amortization	0.5%	185	184	177	190	167	163
Other expenses	-3.1%	1,178	1,216	1,129	1,113	1,091	1,117
Total Expenses	-0.3%	5,060	5,076	4,704	4,612	4,516	4,494
Profit Before exceptional items and Tax	-3.8%	531	552	418	360	362	375
Exceptional items before tax	-	0	0	0	0	0	1.9
Total profit before tax	-3.8%	531	552	418	360	362	377
Current tax	-16.4%	134	160	113	89	113	132
Deferred tax	2233.3%	22	1.9	1.5	21	-4.3	-2.3
Total tax	-3.1%	157	162	114	110	109	130
Total profit (loss) for period	-4.3%	379	396	316	258	254	249
Other comp. income net of taxes	40%	-2.9	-5.5	5.2	-0.2	0.8	-9.26
Total Comprehensive Income	-3.6%	376	390	321	258	255	240
Earnings Per Share, Basic	-1.8%	25.89	26.34	21.23	17.65	17.06	16.2
Earnings Per Share, Diluted	-1.8%	25.89	26.34	21.23	17.65	17.06	16.2

Cash Flow for Apollo Hospitals Enterprises

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	4.6%	250	239	249
Change in inventories	-144.6%	-20.4	49	-166.45
Depreciation	8.7%	399	367	400
Impairment loss / reversal	-	0	0	-1.6
Unrealised forex losses/gains	26.8%	0.1	-0.23	-0.51
Dividend income	68.3%	102	61	0.39
Adjustments for interest income	-10%	37	41	19
Net Cashflows from Operations	-1.7%	1,521	1,548	1,299
Income taxes paid (refund)	2.2%	330	323	98
Net Cashflows From Operating Activities	-2.7%	1,191	1,224	1,201
Proceeds from sales of PPE	-92.5%	1.1	2.33	4.99
Purchase of property, plant and equipment	57%	621	396	463
Proceeds from sales of long-term assets	-	817	0	0
Purchase of other long-term assets	-	1,180	0	0
Cash receipts from repayment of advances and loans made to other parties	0%	16	16	12
Dividends received	68.3%	102	61	0.39
Interest received	-21.7%	19	24	21
Other inflows (outflows) of cash	-73.4%	35	129	-28.34
Net Cashflows From Investing Activities	-41.9%	-835.3	-588.23	-444.6
Proceeds from borrowings	210.7%	464	150	401
Repayments of borrowings	-35.1%	269	414	658
Payments of lease liabilities	17.9%	100	85	0
Dividends paid	-15.4%	216	255	43
Interest paid	0.6%	176	175	248
Net Cashflows from Financing Activities	61.8%	-297	-778.62	-637.22
Net change in cash and cash eq.	140.4%	59	-142.62	119

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	17.9%	449	381	379
Change in inventories	-271.2%	-69.2	42	-175.76
Depreciation	11.7%	687	615	601
Impairment loss / reversal	-	0	0	1.78
Unrealised forex losses/gains	30.2%	0.1	-0.29	-0.55
Adjustments for interest income	-2.3%	43	44	35
Share-based payments	16%	88	76	2.56
Net Cashflows from Operations	35.7%	2,387	1,759	1,820
Income taxes paid (refund)	22.3%	467	382	204
Net Cashflows From Operating Activities	39.5%	1,920	1,377	1,616
Cashflows used in obtaining control of subsidiaries	-94.5%	3.7	50	100
Proceeds from sales of PPE	-70.7%	1.9	4.07	0
Purchase of property, plant and equipment	0.7%	1,137	1,129	657
Proceeds from sales of investment property	-	0	0	5.4
Proceeds from sales of long-term assets	-	817	0	0
Purchase of other long-term assets	-	1,171	0	0
Cash receipts from repayment of advances and loans made to other parties	657.6%	16	2.98	11
Dividends received	-124.8%	0	5.04	0
Interest received	-11.6%	39	44	36
Other inflows (outflows) of cash	-281%	-85.9	49	-153.66
Net Cashflows From Investing Activities	-79.3%	-1,537.1	-856.85	-790.73
Proceeds from changes in ownership interests in subsidiaries	-128.2%	0	4.54	0
Payments from changes in ownership interests in subsidiaries	-	14	0	1
Proceeds from issuing shares	-	2.4	0	0
Proceeds from borrowings	20.9%	707	585	426
Repayments of borrowings	-50.9%	254	516	712
Payments of lease liabilities	-100.5%	0	197	60
Dividends paid	-14.4%	221	258	43
Interest paid	20.8%	303	251	376
Net Cashflows from Financing Activities	50.8%	-311.2	-633.33	-767.7
Net change in cash and cash eq.	162.2%	72	-113.13	57

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

What does Apollo Hospitals Enterprises Ltd. do?

Valuation

Fundamentals

Profitability

Sector Comparison: APOLLOHOSP vs Healthcare Services

Comparative Metrics

Performance Comparison

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Revenue Breakdown

Latest News and Updates from Apollo Hospitals Enterprises

The Bad News

The Good News

Investor Care

Financial Health

Balance Sheet for Apollo Hospitals Enterprises

Updates from Apollo Hospitals Enterprises

Is Apollo Hospitals Enterprises Better than it's peers?

Income Statement for Apollo Hospitals Enterprises

Cash Flow for Apollo Hospitals Enterprises

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)